Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Merck
Boehringer Ingelheim
Express Scripts
AstraZeneca

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR DOXYCYCLINE HYCLATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Doxycycline Hyclate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00041977 ↗ Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea Completed CollaGenex Pharmaceuticals Phase 3 2002-06-01 The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.
NCT00495313 ↗ Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens Completed CollaGenex Pharmaceuticals Phase 4 2007-03-01 To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%
NCT00635609 ↗ Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate Completed Warner Chilcott Phase 4 2008-03-01 Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Doxycycline Hyclate

Condition Name

Condition Name for Doxycycline Hyclate
Intervention Trials
Lymphatic Filariasis 3
Lymphedema 3
Filariasis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Doxycycline Hyclate
Intervention Trials
Acne Vulgaris 5
Lymphedema 3
Filariasis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Doxycycline Hyclate

Trials by Country

Trials by Country for Doxycycline Hyclate
Location Trials
United States 88
Canada 6
Puerto Rico 3
China 2
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Doxycycline Hyclate
Location Trials
New York 6
Florida 6
Pennsylvania 6
California 5
Texas 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Doxycycline Hyclate

Clinical Trial Phase

Clinical Trial Phase for Doxycycline Hyclate
Clinical Trial Phase Trials
Phase 4 6
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Doxycycline Hyclate
Clinical Trial Phase Trials
Completed 12
Recruiting 7
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Doxycycline Hyclate

Sponsor Name

Sponsor Name for Doxycycline Hyclate
Sponsor Trials
United States Agency for International Development (USAID) 3
The Task Force for Global Health 3
Galderma R&D 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Doxycycline Hyclate
Sponsor Trials
Other 32
Industry 8
U.S. Fed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
McKinsey
Baxter
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.